Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Needle-Free Injection System Market

May 2022

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

Mercato dei sistemi di iniezione senza ago per tecnologia (Jet, Spring, Micro-array Patch), per prodotto (Preriempito, Riempibile), Tipo di farmaco (Liquido, Polvere), Applicazione (Vaccinazione, Dermatologia), Utenti finali (Ospedale, Assistenza domiciliare) e Regione (Asia-Pacifico, Nord America, Europa, Sud America, Medio Oriente e Africa) – Previsioni globali dal 2022 al 2029

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Panoramica del mercato dei sistemi di iniezione senza ago


Nel 2020, il mercato globale dei sistemi di iniezione senza ago ha raggiunto i 105,80 milioni di USD e si prevede che crescerà fino a 460,74 milioni di USD entro il 2029, con un tasso di crescita annuale composto (CAGR) del 17,90%.

Gli iniettori senza ago offrono una maggiore sicurezza sia per i pazienti che per gli operatori sanitari, mitigando i rischi associati ai metodi tradizionali di infusione e iniezione, come la necessità di preparazione del farmaco, inserimento dell'ago e gestione e smaltimento degli aghi. Secondo l'American Nurses Association, circa il 74,0% delle ferite accidentali da puntura d'ago derivano da contaminazione, aumentando la probabilità di infezione , che può comportare spese di trattamento sostanziali.






























































ATTRIBUTODETTAGLI
Periodo di studio2020-2029
Anno base2021
Anno stimato2022
Anno previsto2022-2029
Periodo storico2018-2020
UnitàValore (milioni di USD)
SegmentazionePer tecnologia, per prodotto, per tipo di farmaco, per applicazione, per settore di utilizzo finale, per regione
Per tecnologia

  • Getto

  • Primavera

  • Cerotto microarray

  • Altro


Per Prodotto

Per tipo di farmaco

  • Liquido

  • Polvere


Per applicazione

  • Vaccinazione

  • Dermatologia


Per uso finale Industria

  • Ospedale

  • Assistenza domiciliare


Per regione

  • America del Nord

  • Europa

  • Asia-Pacifico

  • MEA

  • America Latina



I Centers for Disease Control and Prevention (CDC) stimano che il costo del trattamento delle ferite da puntura di ago vari da 500 a 3.000 USD per incidente, con costi ancora più elevati in caso di infezione. Il CDC ha previsto un'incidenza annuale di 385.000 ferite da puntura di ago negli ospedali degli Stati Uniti, mentre l'Agenzia europea per la sicurezza e la salute sul lavoro segnala circa 1,0 milioni di tali ferite a livello globale ogni anno.


Le crescenti spese sanitarie pongono sfide significative sia per le economie in via di sviluppo che per quelle sviluppate, che si sforzano di fornire cure convenienti e di alta qualità. Nonostante i programmi di finanziamento e assicurazione sanitaria di supporto, i costi sanitari negli Stati Uniti hanno continuato a crescere costantemente, suscitando preoccupazioni tra gli operatori sanitari. La spesa sanitaria negli Stati Uniti supera la media globale di 2,4 volte e si prevede che aumenterà del 68,0% nel prossimo decennio. L'adozione di iniettori senza ago consente ai pazienti di auto-somministrarsi i farmaci per via sottocutanea nel comfort delle proprie case, riducendo potenzialmente la frequenza delle visite ospedaliere o altre interazioni con le strutture sanitarie. Questo approccio promette di aiutare i pazienti a gestire e ridurre al minimo le spese sanitarie in modo efficace.




[caption id="allegato_9618" align="alignleft" width="870"]Needle-Free Injection System Market | Exactitude Consultancy
Mercato dei sistemi di iniezione senza ago | Exactitude Consultancy
[/didascalia]

Frequently Asked Questions

• What is the Size of global Needle-Free Injection System market?

The Needle-Free Injection System market size had crossed USD 105.80 million in 2020 and is expected to grow till USD 460.74 million by 2029.

• Which is the largest regional market for Needle-Free Injection System market?

The Largest Regional market for Needle-Free Injection System market is North America having a market share of 58%.

• What is the CAGR of Needle-Free Injection System market?

The global Needle-Free Injection System market registered a CAGR of 17.90% from 2022 to 2029.

• Which are the top companies to hold the market share in Needle-Free Injection System market?

Key players profiled in the report include PharmaJet, Portal Instruments, Medical International Technology, Inc (MIT), NuGen Medical Devices, Crossject SA, and Bioject Medical Technologies.

• What are the main industries that Needle-Free Injection System are used in?

Hospital, Homecare, and other sectors are among Needle-Free Injection System' key end-use industries.

• What are the factors Driving the growth of Needle-Free Injection System?

Technological Advancement and Increasing demand for self-injection devices to drive the Needle-Free Injection System Market

Needle-Free Injection System Market Segment Analysis

The Needle-Free Injection System market is segmented by Technology, Product, Type of Medication, Application, End Users.

On the basis of Technology, global Needle-Free Injection System market is segmented into Jet, Spring, Micro-array Patch.

On the basis of Type of Medication, global Needle-Free Injection System market is segmented into Prefilled, Fillable.

On the basis of Application, global Needle-Free Injection System market is segmented into Liquid, Powder.

On the basis of End Users, global Needle-Free Injection System market is segmented into Hospital, Homecare.

[caption id="attachment_9587" align="alignleft" width="680"]Needle-Free Injection System Market | Exactitude Consultancy
Needle-Free Injection System Market | Exactitude Consultancy
[/caption]
Needle-Free Injection System Market Players

The Key Players in Needle-Free Injection System Market are PharmaJet, Portal Instruments, Medical International Technology, Inc (MIT), NuGen Medical Devices, Crossject SA, and Bioject Medical Technologies.

Market leaders are putting a premium on new product releases, as well as other organic growth methods like patents and events. Acquisitions, as well as partnerships and collaborations, were considered inorganic growth tactics in the market. As a consequence of these efforts, market participants may now be able to expand their business and client base. In the future, industry participants in the needle-free injection system market are projected to benefit from excellent development opportunities.

Who Should Buy? Or Key Stakeholders

  • Industry and consulting firms
  • State and national regulatory authorities
  • Investors
  • Suppliers and Distributors
  • Research Institutes
  • Others

Key Takeaways:

  • The global Needle-Free Injection System market is expected to grow at a Compound annual growth rate (CAGR) of 17.90%.
  • On the basis of Technology, global Needle-Free Injection System market is segmented into Jet, Spring, Micro-array Patch.
  • On the basis of Type of Medication, global Needle-Free Injection System market is segmented into Prefilled, Fillable.
  • On the basis of Application, global Needle-Free Injection System market is segmented into Liquid, Powder.
  • On the basis of End Users, global Needle-Free Injection System market is segmented into Hospital, Homecare.
  • North America led the needle-free injection market with a 58 percent share.
  • The major trend in the Needle-Free Injection System Market is the growing demand for painless drug delivery methods.

Needle-Free Injection System Market Regional Analysis

Geographically, Needle-Free Injection System market is segmented into North America, Europe, Asia Pacific, and Rest of the world.

  • North America: includes the US, Canada, Mexico
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC

North America led the needle-free injection market with a 58 percent share, followed by Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa. During the projected period, however, the APAC region is predicted to develop at the fastest rate. The rapidly developing healthcare industries in China and India, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals and clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for self-injectable device testing are all driving market growth in the APAC region.

[caption id="attachment_9633" align="alignleft" width="680"]Needle-Free Injection System Market | Exactitude Consultancy
Needle-Free Injection System Market | Exactitude Consultancy
[/caption]

Key Market Segments: Needle-Free Injection System Market

Needle-Free Injection System Market by Technology, 2020-2029 (USD Millions)
  • Jet
  • Spring
  • Micro-Array Patch
  • Other
Needle-Free Injection System Market by Product, 2020-2029 (USD Millions)
  • Prefilled
  • Fillable
Needle-Free Injection System Market by Type of Medication, 2020-2029 (USD Millions)
  • Liquid
  • Powder
Needle-Free Injection System Market by Application, 2020-2029 (USD Millions)
  • Vaccination
  • Dermatology
Needle-Free Injection System Market by End Use Industry, 2020-2029 (USD Millions)
  • Hospital
  • Homecare
Needle-Free Injection System Market by Region, 2020-2029 (USD Millions)
  • North America
  • Europe
  • APAC
  • MEA
  • Latin America
Important Countries In All Regions Are Covered.

Objectives of the Study

  • To provide an overall view of the market.
  • To detail out key pointers such as growth, market size, trends, drivers, restraints, challenges and opportunities in quantitative and qualitative terms
  • To provide a holistic view of market players and their activities to get an understanding of key growth strategies adopted

Key Question Answered

  • What is the current market size of this high growth market?
  • What is the overall growth rate?
  • What are the key growth areas, applications, end uses and types?
  • Key reasons for growth
  • Challenges for growth
  • What technological developments are happening in this area?

  1. Introduzione

    1. Definizione di mercato

    2. Segmentazione del mercato

    3. Cronologie della ricerca

    4. Presupposti e limitazioni



  2. Metodologia di ricerca

    1. Estrazione dei dati

      1. Ricerca secondaria

      2. Ricerca primaria

      3. Consigli degli esperti in materia



    2. Controlli di qualità

      1. Revisione finale



    3. Triangolazione dei dati

      1. Approccio dal basso verso l'alto

      2. Approccio dall'alto verso il basso

      3. Flusso di ricerca



    4. Fonti dei dati



  3. Sintesi

  4. Panoramica del mercato

    1. Prospettive di mercato globali dei sistemi di iniezione senza ago

      1. Fattori trainanti del mercato

      2. Limitazioni di mercato

      3. Opportunità di mercato



    2. Impatto del Covid-19 sul mercato dei sistemi di iniezione senza ago

    3. Le cinque forze di Porter Tipo

      1. Minaccia da parte dei nuovi entranti

      2. Minaccia da sostituti

      3. Potere contrattuale dei fornitori

      4. Potere contrattuale dei clienti

      5. Grado di concorrenza



    4. Analisi della catena del valore del settore



  5. Mercato globale dei sistemi di iniezione senza ago per tecnologia

    1. Getto

    2. Primavera

    3. Cerotto microarray

    4. Altro



  6. Mercato globale dei sistemi di iniezione senza ago per prodotto

    1. Precompilato

    2. Compilabile



  7. Mercato globale dei sistemi di iniezione senza ago per tipo di farmaco

    1. Liquido

    2. Polvere



  8. Mercato globale dei sistemi di iniezione senza ago per applicazione

    1. Vaccinazione

    2. Dermatologia



  9. Mercato globale dei sistemi di iniezione senza ago per settore di utilizzo finale

    1. Ospedale

    2. Assistenza domiciliare



  10. Mercato globale dei sistemi di iniezione senza ago per regione

    1. America del Nord

      1. NOI

      2. Canada

      3. Messico



    2. Sud America

      1. Brasile

      2. Argentina

      3. Colombia

      4. Resto del Sud America



    3. Europa

      1. Germania

      2. Regno Unito

      3. Francia

      4. Italia

      5. Spagna

      6. Russia

      7. Resto d'Europa



    4. Asia Pacifico

      1. India

      2. Cina

      3. Giappone

      4. Corea del Sud

      5. Australia

      6. Asia sud-orientale

      7. Resto dell'Asia Pacifica



    5. Medio Oriente e Africa

      1. Emirati Arabi Uniti

      2. Arabia Saudita

      3. Sudafrica

      4. Resto del Medio Oriente e Africa







  1. Profili aziendali* (panoramica aziendale, istantanea aziendale, prodotti offerti, sviluppi recenti)



  1. FarmaciaJet

  2. Strumenti del portale

  3. Tecnologia medica internazionale, Inc. (MIT)

  4. Dispositivi medici NuGen

  5. Crossject SA Bioject Medical Technologies  *L'elenco delle aziende è indicativo


 

ELENCO DELLE TABELLE


TABLE 1           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 2           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 3           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 4           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 5           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 6           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 7           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 8           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 9           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 10        US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 11        US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 12        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 13        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 14        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 15        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 17        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 18        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 19        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 20        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 21        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 22        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 23        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 24        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 25        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 26        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 27        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 28        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 29        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 30        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 31        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 32        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 33        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 34        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 35        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 36        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 37        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 38        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 39        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 40        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 41        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 42        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 43        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 44        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 45        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 47        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 48        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 49        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 50        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 51        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 52        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 53        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 54        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 55        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 56        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 57        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 58        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 59        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 60        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 61        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 62        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 63        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 64        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 65        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 66        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 67        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 68        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 69        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 70        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 71        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 72        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 73        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 74        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 75        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 77        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 78        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 79        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 80        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 81        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 82        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 83        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 84        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 85        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 86        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 87        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 88        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 89        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 90        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 91        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 92        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 93        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 94        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 95        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 96        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 97        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 98        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 99        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 100      SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 101      SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 102      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 103      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 104      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 105      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 106      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 107      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 108      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 109      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 110      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 111      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 112      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 113      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 114      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 115      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 116      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 117      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 118      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 119      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 120      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 121      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 122      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 123      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 124      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 125      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 126      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 127      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 128      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 129      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 130      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 131      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

 

LIST OF FIGURES


FIGURE 1              MARKET DYNAMICS

FIGURE 2              MARKET SEGMENTATION

FIGURE 3              REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4              DATA TRIANGULATION

FIGURE 5              BOTTOM-UP APPROACH

FIGURE 6              TOP-DOWN APPROACH

FIGURE 7              RESEARCH FLOW

FIGURE 8        GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 9        GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY PRODUCT USD MILLION, 2020-2029

FIGURE 10     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TYPE OF MEDICATIONR, USD MILLION, 2020-2029

FIGURE 11     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 13     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12     PORTER’S FIVE FORCES TYPE

FIGURE 13     NORTH AMERICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 14     EUROPE NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 15     ASIA PACIFIC NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 16           SOUTH AMERICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 17           MIDDLE EAST & AFRICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 18           PHARMAJETCOMPANY SNAPSHOT

FIGURE 19           PORTAL INSTRUMENTSCOMPANY SNAPSHOT

FIGURE 20           MEDICAL INTERNATIONAL TECHNOLOGY, INC (MIT)COMPANY SNAPSHOT

FIGURE 21           NUGEN MEDICAL DEVICESCOMPANY SNAPSHOT

FIGURE 22           CROSSJECT SA BIOJECT MEDICAL TECHNOLOGIESCOMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
6719

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.